We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Biofrontera Inc | NASDAQ:BFRIW | NASDAQ | Equity Warrant |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.0028 | -11.20% | 0.0222 | 0.0173 | 0.025 | 0.0222 | 0.0151 | 0.0151 | 818 | 19:40:52 |
Event: | LD Micro Main Event XV |
Date: | Wednesday, October 26, 2022 |
Presentation Time: | 4:00 PM Pacific Time (7:00 PM Eastern Time) |
Location: | Luxe Sunset Boulevard Hotel, Los Angeles, CA |
Webcast: | https://me22.sequireevents.com |
A webcast of the presentation will be live and archived on the News & Events section of the company website. Institutional investors registered for the conference who would like to meet with Erica Monaco and Hermann Lübbert, Executive Chairman of Biofrontera Inc., please contact LD Micro directly or the BFRI investor relations team.
About Biofrontera Inc.
Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company’s licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit www.biofrontera-us.com.
Contacts
Biofrontera Inc.Anke zur Mühlen+1 781 486 1539us-ir@biofrontera.com
LHA Investor RelationsTirth T. Patel+1 212 201 6614tpatel@lhai.com
# # #
1 Year Biofrontera Chart |
1 Month Biofrontera Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions